Development and specific induction of apoptosis of cultured cell models overexpressing human tau during neural differentiation: Implication in Alzheimer's disease

Analytical Biochemistry

Volumn 360, Issue 1, 2007, Pages 114-122

  Tsukane, Mariko ^a   Yoshizaki, Chihiro ^a   Yamauchi, Takashi ^a  

^a Graduate School of Pharmaceutical Sciences   (Japan)

Author keywords

Alzheimer's disease; Apoptosis; Neural differentiation; NG108 15; P19; Tau

Indexed keywords

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SIGNALING; PROTEINS;

ALZHEIMER'S DISEASE; GLYCOGEN SYNTHASE KINASE-3; HYPERPHOSPHORYLATED; MICROTUBULE ASSOCIATED PROTEIN; NEURAL DIFFERENTIATIONS; NEURODEGENERATIVE DISORDERS; NG108-15; PROGRAMMED CELL DEATHS;

NEURODEGENERATIVE DISEASES;

COMPLEMENTARY DNA; CYCLIC AMP; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM CHLORIDE; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; SMALL INTERFERING RNA; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GLIOMA CELL; HYBRID CELL; IMMUNOBLOTTING; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33845500106     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.10.003     Document Type: Article

References (25)

1. Price D.L., and Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21 (1998) 479-505
2. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
3. Spillantini M.G., and Goedert M. Tau protein pathology in neurodegenerative disease. Trends Neurosci. 21 (1998) 428-433
4. Alonso A.C., Zaidi T., Novak M., Grandke-Iqbal I., and Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. USA 98 (2001) 6923-6928
5. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation, and role in neurodegenerative disorders. Brain Res. Rev. 33 (2000) 95-130
6. Oddo S., Caccamo1 A., Shepherd1 J.D., Murphy M.P., Golde T.E., Kayed R., Metherate1 R., Mattson M.P., Akbari Y., and LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39 (2003) 409-421
7. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
8. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 (1989) 519-526
9. Rudnicki M.A., and McBurney M.W. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (1987), IRL Press, Oxford, UK 19-49
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
11. 2+/Calmodulin-dependent protein kinase II in the rat cerebellum: an immunohistochemical study with monoclonal antibodies specific to either α or β subunit. J. Chem. Neuroanat. 5 (1992) 383-390
12. 2+/calmodulin-dependent protein kinase II involved in stimulation of neurite outgrowth in neuroblastoma cells. Brain Res. 881 (2000) 165-175
13. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., and Nicolson D.W. A combinational approach defines specificities of members of the caspase family and granzime B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272 (1997) 17907-17911
14. Mookherjee P., and Johnson G.V.W. Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells. Brain Res. 921 (2001) 31-43
15. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
16. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6 (1996) 1664-1668
17. Planel E., Sun X., and Takashima A. Role of GSK-3 in Alzheimer's disease pathology. Drug Dev. Res. 56 (2002) 491-510
18. Khatoon S., Grundke-Iqbal I., and Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59 (1992) 750-753
19. Tsukane M., and Yamauchi T. Increase in apoptosis with neural differentiation and shortening of the lifespan of P19 cells overexpressing tau. Neurochem. Intl. 48 (2006) 243-254
20. Yoshizaki C., Tsukane M., and Yamauchi T. Overexpression of tau leads to the stimulation of neurite outgrowth, the activation of caspase 3 activity, and accumulation and phosphorylation of tau in neuroblastoma cells on cAMP treatment. Neurosci. Res. 49 (2004) 363-371
21. Shelton S.B., and Johnson G.V.W. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J. Neurosci. Res. 66 (2001) 203-213
22. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E.-M., and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143 (1998) 777-794
23. Fath T., Eidenmuller J., and Brandt R. Tau-mediated cytotoxicity in a seudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22 (2002) 9733-9741
24. Khlistunova I., Biernat1 J., Wang Y., Pickhardt M., von Bergen M., Gazova Z., Mandelkow E.-M., and Mandelkow E. Inducible expression of tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J. Biol. Chem. 281 (2006) 1205-1214
25. Bhat R.V., Haeberlein S.L.B., and Avila J. Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem. 89 (2004) 1313-1317